株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

創薬サービスの世界市場(種類・プロセス・医薬品タイプ・治療分野別):産業展望、包括的分析、将来予測

Drug Discovery Services Market by Type, by Process, by Drug Type, and by Therapeutic Area: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018-2025

発行 Zion Market Research 商品コード 843092
出版日 ページ情報 英文 110 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.30円で換算しております。
創薬サービスの世界市場(種類・プロセス・医薬品タイプ・治療分野別):産業展望、包括的分析、将来予測 Drug Discovery Services Market by Type, by Process, by Drug Type, and by Therapeutic Area: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018-2025
出版日: 2019年02月26日 ページ情報: 英文 110 Pages
概要

当レポートでは、世界の創薬サービス市場を調査し、市場および産業の概要、種類・プロセス・医薬品タイプ・治療分野・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

第1章 イントロダクション

  • レポート概要と範囲
  • 調査範囲
  • 調査手法

第2章 エグゼクティブサマリー

  • 市場規模の推移と予測(金額ベース)
  • 市場スナップショット

第3章 産業力学

  • イントロダクション
  • 成長要因
  • 阻害要因
  • 市場機会
  • ファイブフォース分析
  • 市場魅力分析:セグメント別

第4章 競合環境

  • 市場シェアの分析
  • 戦略動向
    • 合併・買収
    • 新材料の登場
    • 合意・パートナーシップ・コラボレーション・合弁事業
    • 研究開発・事業拡大

第5章 創薬サービスの世界市場:種類別

  • 市場概要
  • 薬物動態・薬物代謝
  • バイオロジーサービス
  • 医薬品化学
  • その他

第6章 創薬サービスの世界市場:プロセス別

  • 市場概要
  • ターゲット同定
  • ターゲット選別
  • リード化合物探索
  • ターゲット検証
  • リード最適化

第7章 創薬サービスの世界市場:医薬品タイプ別

  • 市場概要
  • 生物学的製剤
  • 低分子医薬品

第8章 創薬サービスの世界市場:治療分野別

  • 市場概要
  • 神経疾患
  • 糖尿病
  • 癌・腫瘍
  • 呼吸器疾患
  • 心血管疾患
  • その他

第9章 創薬サービスの世界市場:地域別

  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 企業プロファイル

  • Albany Molecular Research Inc.
  • Thermo Fisher Scientific
  • Biogen
  • Evotec
  • Charles River Laboratories International
  • Domainex
  • Covance
  • Selcia Limited
  • WuXiAppTec
  • Viva Biotech
  • Pharmaceutical Product Development, LLC
  • SRI International
目次

The report covers a forecast and an analysis of the drug discovery services market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the drug discovery services market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the drug discovery services market on a global and regional level.

In order to give the users of this report a comprehensive view of the drug discovery services market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the drug discovery services market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new product launch, agreements, partnerships, collaborations joint ventures, research development, and regional expansion of major participants involved in the drug discovery services market on a global and regional basis.

The study provides a decisive view of the drug discovery services market by segmenting the market based on type, process, drug type, therapeutic area, and region. By type, the drug discovery services market is segmented into pharmacokinetics and drug metabolism, biology services, and medicinal chemistry. The process segment includes target validation, target selection, hit-to-lead identification, candidate validation, and lead optimization. The drug type segment includes biologics and small molecules. The therapeutic area segment includes neurology, diabetes, oncology, respiratory diseases, cardiovascular diseases, and others.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global drug discovery services market are Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific, Evotec, Charles River Laboratories International, Domainex, Covance, GenScript, Selcia Limited, WuXiAppTec, Viva Biotech, Pharmaceutical Product Development, LLC, and SRI International, among others.

This report segments the global drug discovery services market into:

Global Drug Discovery Services Market: By Type

  • Pharmacokinetics and Drug Metabolism
  • Biology Services
  • Medicinal Chemistry

Global Drug Discovery Services Market: By Process

  • Target Validation
  • Target Selection
  • Hit-To-Lead Identification
  • Candidate Validation
  • Lead Optimization

Global Drug Discovery Services Market: By Drug Type

  • Biologics
  • Small Molecules

Global Drug Discovery Services Market: By Therapeutic Area

  • Neurology
  • Diabetes
  • Oncology
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Others

Global Drug Discovery Services Market: By Region

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa

Table Of Contents

Chapter 1. Introduction

  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology

Chapter 2. Executive Summary

  • 2.1. Global Drug Discovery Services market, 2018-2025(USD Billion)
  • 2.2. Global Drug Discovery Services market: Snapshot

Chapter 3. Drug Discovery Services Market - Industry Dynamics

  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Rising expenditure on research and development
    • 3.2.2. Growing inclination of pharmaceutical companies toward outsourcing to evade hurdles
  • 3.3. Market Restraints
    • 3.3.1. High costs of drug discovery
    • 3.3.2. Strict guidelines in some regions
  • 3.4. Opportunities
    • 3.4.1. Patent expiry of current products
    • 3.4.2. Technological improvements in drug discovery services
  • 3.5. Porter's Five Forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. The threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Type
    • 3.6.2. Market attractiveness analysis, by Process
    • 3.6.3. Market attractiveness analysis, by Drug Type
    • 3.6.4. Market attractiveness analysis, by Therapeutic Area

Chapter 4. Global Drug Discovery Services Market - Competitive Landscape

  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Drug Discovery Services market: company market share, 2018
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Product Launch
    • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
    • 4.2.4. Research and Development and Regional Expansion

Chapter 5. Global Drug Discovery Services Market - Type Analysis

  • 5.1. Global Drug Discovery Services market: Type overview
    • 5.1.1. Global Drug Discovery Services market revenue share, by Type, 2018 and 2025
  • 5.2. Pharmacokinetics and Drug Metabolism
    • 5.2.1. Global Drug Discovery Services market for Pharmacokinetics and Drug Metabolism, 2016-2025 (USD Billion)
  • 5.3. Biology Services
    • 5.3.1. Global Drug Discovery Services market for Biology Services, 2016-2025 (USD Billion)
  • 5.4. Medicinal Chemistry
    • 5.4.1. Global Drug Discovery Services market for Medicinal Chemistry, 2016-2025 (USD Billion)

Chapter 6. Global Drug Discovery Services Market - Process Analysis

  • 6.1. Global Drug Discovery Services market: Process overview
    • 6.1.1. Global Drug Discovery Services market revenue share, by Process, 2018 and 2025
  • 6.2. Target Validation
    • 6.2.1. Global Drug Discovery Services market for Target Validation, 2016-2025 (USD Billion)
  • 6.3. Target Selection
    • 6.3.1. Global Drug Discovery Services market for Target Selection, 2016-2025 (USD Billion)
  • 6.4. Hit-to-lead Identification
    • 6.4.1. Global Drug Discovery Services market for Hit-to-lead Identification, 2016-2025 (USD Billion)
  • 6.5. Candidate Validation
    • 6.5.1. Global Drug Discovery Services market for Candidate Validation, 2016-2025 (USD Billion)
  • 6.6. Lead Optimization
    • 6.6.1. Global Drug Discovery Services market for Lead Optimization, 2016-2025 (USD Billion)

Chapter 7. Global Drug Discovery Services Market - Drug Type Analysis

  • 7.1. Global Drug Discovery Services market: Drug Type overview
    • 7.1.1. Global Drug Discovery Services market revenue share, by Drug Type, 2018 and 2025
  • 7.2. Biologics
    • 7.2.1. Global Drug Discovery Services market for Biologics, 2016-2025 (USD Billion)
  • 7.3. Small Molecules
    • 7.3.1. Global Drug Discovery Services market for Small Molecules, 2016-2025 (USD Billion)

Chapter 8. Global Drug Discovery Services Market - Therapeutic Area Analysis

  • 8.1. Global Drug Discovery Services market: Therapeutic Area overview
    • 8.1.1. Global Drug Discovery Services market revenue share, by Therapeutic Area, 2018 and 2025
  • 8.2. Neurology
    • 8.2.1. Global Drug Discovery Services market for Neurology, 2016-2025 (USD Billion)
  • 8.3. Diabetes
    • 8.3.1. Global Drug Discovery Services market for Diabetes, 2016-2025 (USD Billion)
  • 8.4. Oncology
    • 8.4.1. Global Drug Discovery Services market for Oncology, 2016-2025 (USD Billion)
  • 8.5. Respiratory Diseases
    • 8.5.1. Global Drug Discovery Services market for Respiratory Diseases, 2016-2025 (USD Billion)
  • 8.6. Cardiovascular Diseases
    • 8.6.1. Global Drug Discovery Services market for Cardiovascular Diseases, 2016-2025 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Drug Discovery Services market for Others, 2016-2025 (USD Billion)

Chapter 9. Global Drug Discovery Services Market - Regional Analysis

  • 9.1. Global Drug Discovery Services market: Regional overview
    • 9.1.1. Global Drug Discovery Services market revenue share, by region, 2018 and 2025
  • 9.2. North America
    • 9.2.1. North America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
    • 9.2.2. North America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
    • 9.2.3. North America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
    • 9.2.4. North America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.2.5. The U.S.
      • 9.2.5.1. The U.S. Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.2.5.2. The U.S. Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.2.5.3. The U.S. Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.2.5.4. The U.S. Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.2.6. Rest of North America
      • 9.2.6.1. Rest of North America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.2.6.2. Rest of North America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.2.6.3. Rest of North America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.2.6.4. Rest of North America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
  • 9.3. Europe
    • 9.3.1. Europe Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
    • 9.3.2. Europe Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
    • 9.3.3. Europe Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
    • 9.3.4. Europe Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.3.5. Germany
      • 9.3.5.1. Germany Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.3.5.2. Germany Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.3.5.3. Germany Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.3.5.4. Germany Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.3.6. UK
      • 9.3.6.1. UK Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.3.6.2. UK Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.3.6.3. UK Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.3.6.4. UK Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.3.7. France
      • 9.3.7.1. France Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.3.7.2. France Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.3.7.3. France Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.3.7.4. France Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.3.8. Rest of Europe
      • 9.3.8.1. Rest of Europe Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.3.8.2. Rest of Europe Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.3.8.3. Rest of Europe Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.3.8.4. Rest of Europe Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
    • 9.4.2. Asia Pacific Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
    • 9.4.3. Asia Pacific Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
    • 9.4.4. Asia Pacific Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.4.5. China
      • 9.4.5.1. China Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.4.5.2. China Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.4.5.3. China Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.4.5.4. China Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.4.6. Japan
      • 9.4.6.1. Japan Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.4.6.2. Japan Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.4.6.3. Japan Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.4.6.4. Japan Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.4.7. India
      • 9.4.7.1. India Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.4.7.2. India Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.4.7.3. India Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.4.7.4. India Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.4.8. Rest of Asia Pacific
      • 9.4.8.1. Rest of Asia Pacific Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.4.8.2. Rest of Asia Pacific Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.4.8.3. Rest of Asia Pacific Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.4.8.4. Rest of Asia Pacific Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
  • 9.5. Latin America
    • 9.5.1. Latin America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
    • 9.5.2. Latin America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
    • 9.5.3. Latin America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
    • 9.5.4. Latin America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.5.5. Brazil
      • 9.5.5.1. Brazil Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.5.5.2. Brazil Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.5.5.3. Brazil Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.5.5.4. Brazil Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.5.6. Rest of Latin America
      • 9.5.6.1. Rest of Latin America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.5.6.2. Rest of Latin America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.5.6.3. Rest of Latin America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.5.6.4. Rest of Latin America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
  • 9.6. The Middle East and Africa
    • 9.6.1. The Middle East and Africa Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
    • 9.6.2. The Middle East and Africa Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
    • 9.6.3. The Middle East and Africa Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
    • 9.6.4. The Middle East and Africa Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)

Chapter 10. Company Profile

  • 10.1. Albany Molecular Research Inc. (AMRI)
    • 10.1.1. Overview
    • 10.1.2. Financials
    • 10.1.3. Drug Type portfolio
    • 10.1.4. Business strategy
    • 10.1.5. Recent developments
  • 10.2. Thermo Fisher Scientific
    • 10.2.1. Overview
    • 10.2.2. Financials
    • 10.2.3. Drug Type portfolio
    • 10.2.4. Business strategy
    • 10.2.5. Recent developments
  • 10.3. Biogen
    • 10.3.1. Overview
    • 10.3.2. Financials
    • 10.3.3. Drug Type portfolio
    • 10.3.4. Business strategy
    • 10.3.5. Recent developments
  • 10.4. Evotec
    • 10.4.1. Overview
    • 10.4.2. Financials
    • 10.4.3. Drug Type portfolio
    • 10.4.4. Business strategy
    • 10.4.5. Recent developments
  • 10.5. Charles River Laboratories International
    • 10.5.1. Overview
    • 10.5.2. Financials
    • 10.5.3. Drug Type portfolio
    • 10.5.4. Business strategy
    • 10.5.5. Recent developments
  • 10.6. Domainex
    • 10.6.1. Overview
    • 10.6.2. Financials
    • 10.6.3. Drug Type portfolio
    • 10.6.4. Business strategy
    • 10.6.5. Recent developments
  • 10.7. Covance
    • 10.7.1. Overview
    • 10.7.2. Financials
    • 10.7.3. Drug Type portfolio
    • 10.7.4. Business strategy
    • 10.7.5. Recent developments
  • 10.8. GenScript
    • 10.8.1. Overview
    • 10.8.2. Financials
    • 10.8.3. Drug Type portfolio
    • 10.8.4. Business strategy
    • 10.8.5. Recent developments
  • 10.9. Selcia Limited
    • 10.9.1. Overview
    • 10.9.2. Financials
    • 10.9.3. Drug Type portfolio
    • 10.9.4. Business strategy
    • 10.9.5. Recent developments
  • 10.10. WuXiAppTec
    • 10.10.1. Overview
    • 10.10.2. Financials
    • 10.10.3. Drug Type portfolio
    • 10.10.4. Business strategy
    • 10.10.5. Recent developments
  • 10.11. Viva Biotech
    • 10.11.1. Overview
    • 10.11.2. Financials
    • 10.11.3. Drug Type portfolio
    • 10.11.4. Business strategy
    • 10.11.5. Recent developments
  • 10.12. Pharmaceutical Product Development, LLC
    • 10.12.1. Overview
    • 10.12.2. Financials
    • 10.12.3. Drug Type portfolio
    • 10.12.4. Business strategy
    • 10.12.5. Recent developments
  • 10.13. SRI International
    • 10.13.1. Overview
    • 10.13.2. Financials
    • 10.13.3. Drug Type portfolio
    • 10.13.4. Business strategy
    • 10.13.5. Recent developments